Abstract: This invention relates to a novel compound, dicreatine malate, comprising approximately two moles of creatine cations per one mole of malate anion. The creatine salt of this invention has been found to increase the bioavailability of both the creatine and malic acid moieties over and above the individual bioavailabilities of creatine monohydrate and malic acid base. Dicreatine malate vastly improves the production of Adenosine TriPhosphate (ATP) beyond the level of creatine monohydrate or any other creatine derivative. It also has a much greater efficacy in uses such as increasing muscle mass, increasing cell volumization, decreasing adipose stores, and for increasing overall strength and endurance.

Abstract: Forskolin is disclosed to have novel effects on humans such as stimulating various aspects of the metabolism so that the overall effect is one of perceived increased energy levels and improved mental alertness. As part of this psychostimulation, forskolin shows a profound effect to reduce a human's appetite for food. Forskolin can be safely used either as a drug or as a food or dietary supplement to decrease a human's food intake. It can likewise be safely used as a mental stimulant so that the person experiences a heightened sense of energy levels as well as mental alertness.

Abstract: Octopamine salts are disclosed which have powerful metabolic enhancing effects in humans via oral administration. These salts not only have increased stability but also greatly increased bioavailability over the base form. The metabolic enhancing properties include positive blood sugar regulation, increased thermogenesis and fat loss, increased anticatabolism/anabolism, decreased appetite, improved mental focus and psychological outlook and increased energy production and anti-fatigue actions.